vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and CBAK Energy Technology, Inc. (CBAT). Click either name above to swap in a different company.
CBAK Energy Technology, Inc. is the larger business by last-quarter revenue ($58.8M vs $44.9M, roughly 1.3× AbCellera Biologics Inc.). CBAK Energy Technology, Inc. runs the higher net margin — -12.5% vs -19.9%, a 7.4% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 131.8%). CBAK Energy Technology, Inc. produced more free cash flow last quarter ($16.1M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -0.0%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.
ABCL vs CBAT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $58.8M |
| Net Profit | $-8.9M | $-7.4M |
| Gross Margin | — | 7.3% |
| Operating Margin | -63.7% | -13.6% |
| Net Margin | -19.9% | -12.5% |
| Revenue YoY | 788.4% | 131.8% |
| Net Profit YoY | 73.9% | -63.6% |
| EPS (diluted) | $-0.03 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $58.8M | ||
| Q3 25 | $9.0M | $60.9M | ||
| Q2 25 | $17.1M | $40.5M | ||
| Q1 25 | $4.2M | $34.9M | ||
| Q4 24 | $5.0M | $25.4M | ||
| Q3 24 | $6.5M | $44.6M | ||
| Q2 24 | $7.3M | $47.8M | ||
| Q1 24 | $10.0M | $58.8M |
| Q4 25 | $-8.9M | $-7.4M | ||
| Q3 25 | $-57.1M | $2.7M | ||
| Q2 25 | $-34.7M | $-3.1M | ||
| Q1 25 | $-45.6M | $-1.6M | ||
| Q4 24 | — | $-4.5M | ||
| Q3 24 | $-51.1M | $17.6K | ||
| Q2 24 | $-36.9M | $6.4M | ||
| Q1 24 | $-40.6M | $9.8M |
| Q4 25 | — | 7.3% | ||
| Q3 25 | — | 8.0% | ||
| Q2 25 | — | 11.0% | ||
| Q1 25 | — | 13.7% | ||
| Q4 24 | — | 13.1% | ||
| Q3 24 | — | 15.6% | ||
| Q2 24 | — | 26.6% | ||
| Q1 24 | — | 31.9% |
| Q4 25 | -63.7% | -13.6% | ||
| Q3 25 | -851.8% | -6.6% | ||
| Q2 25 | -290.2% | -8.7% | ||
| Q1 25 | -1479.6% | -8.2% | ||
| Q4 24 | — | -26.0% | ||
| Q3 24 | -1439.4% | -1.9% | ||
| Q2 24 | -1276.2% | 12.4% | ||
| Q1 24 | -551.5% | 17.4% |
| Q4 25 | -19.9% | -12.5% | ||
| Q3 25 | -637.8% | 4.4% | ||
| Q2 25 | -203.3% | -7.6% | ||
| Q1 25 | -1077.2% | -4.5% | ||
| Q4 24 | — | -17.8% | ||
| Q3 24 | -785.4% | 0.0% | ||
| Q2 24 | -504.3% | 13.5% | ||
| Q1 24 | -408.0% | 16.7% |
| Q4 25 | $-0.03 | $-0.08 | ||
| Q3 25 | $-0.19 | $0.03 | ||
| Q2 25 | $-0.12 | $-0.03 | ||
| Q1 25 | $-0.15 | $-0.02 | ||
| Q4 24 | — | $-0.05 | ||
| Q3 24 | $-0.17 | $0.00 | ||
| Q2 24 | $-0.13 | $0.07 | ||
| Q1 24 | $-0.14 | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $8.3M |
| Total DebtLower is stronger | — | $4.1M |
| Stockholders' EquityBook value | $966.9M | $112.7M |
| Total Assets | $1.4B | $426.2M |
| Debt / EquityLower = less leverage | — | 0.04× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $8.3M | ||
| Q3 25 | $83.2M | $10.5M | ||
| Q2 25 | $92.4M | $45.7M | ||
| Q1 25 | $159.3M | $9.6M | ||
| Q4 24 | $156.3M | $11.0M | ||
| Q3 24 | $126.6M | $24.2M | ||
| Q2 24 | $148.3M | $44.1M | ||
| Q1 24 | $123.6M | $23.8M |
| Q4 25 | — | $4.1M | ||
| Q3 25 | — | $4.8M | ||
| Q2 25 | — | $4.9M | ||
| Q1 25 | — | $4.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $966.9M | $112.7M | ||
| Q3 25 | $964.0M | $121.4M | ||
| Q2 25 | $1.0B | $118.2M | ||
| Q1 25 | $1.0B | $120.8M | ||
| Q4 24 | $1.1B | $121.7M | ||
| Q3 24 | $1.1B | $131.2M | ||
| Q2 24 | $1.1B | $126.6M | ||
| Q1 24 | $1.1B | $120.9M |
| Q4 25 | $1.4B | $426.2M | ||
| Q3 25 | $1.4B | $363.9M | ||
| Q2 25 | $1.4B | $333.1M | ||
| Q1 25 | $1.3B | $311.5M | ||
| Q4 24 | $1.4B | $302.2M | ||
| Q3 24 | $1.4B | $293.5M | ||
| Q2 24 | $1.4B | $279.6M | ||
| Q1 24 | $1.5B | $286.5M |
| Q4 25 | — | 0.04× | ||
| Q3 25 | — | 0.04× | ||
| Q2 25 | — | 0.04× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $29.8M |
| Free Cash FlowOCF − Capex | $-44.6M | $16.1M |
| FCF MarginFCF / Revenue | -99.4% | 27.3% |
| Capex IntensityCapex / Revenue | 21.9% | 23.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $3.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $29.8M | ||
| Q3 25 | $-52.6M | $14.6M | ||
| Q2 25 | $-32.4M | $13.8M | ||
| Q1 25 | $-11.6M | $-9.6M | ||
| Q4 24 | $-108.6M | $9.6M | ||
| Q3 24 | $-28.9M | $19.7M | ||
| Q2 24 | $-30.0M | $2.9M | ||
| Q1 24 | $-41.7M | $7.4M |
| Q4 25 | $-44.6M | $16.1M | ||
| Q3 25 | $-61.5M | $6.0M | ||
| Q2 25 | $-45.8M | $4.1M | ||
| Q1 25 | $-22.2M | $-22.3M | ||
| Q4 24 | $-187.0M | $3.9M | ||
| Q3 24 | $-47.4M | $16.5M | ||
| Q2 24 | $-50.1M | $2.5M | ||
| Q1 24 | $-65.8M | $-454.0K |
| Q4 25 | -99.4% | 27.3% | ||
| Q3 25 | -687.0% | 9.9% | ||
| Q2 25 | -267.9% | 10.2% | ||
| Q1 25 | -524.0% | -63.9% | ||
| Q4 24 | -3702.8% | 15.5% | ||
| Q3 24 | -728.4% | 37.1% | ||
| Q2 24 | -683.8% | 5.2% | ||
| Q1 24 | -661.5% | -0.8% |
| Q4 25 | 21.9% | 23.4% | ||
| Q3 25 | 99.7% | 14.1% | ||
| Q2 25 | 78.2% | 23.8% | ||
| Q1 25 | 251.1% | 36.3% | ||
| Q4 24 | 1552.7% | 22.5% | ||
| Q3 24 | 284.6% | 7.0% | ||
| Q2 24 | 274.6% | 0.9% | ||
| Q1 24 | 242.5% | 13.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | 5.51× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1115.72× | ||
| Q2 24 | — | 0.46× | ||
| Q1 24 | — | 0.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
CBAT
| Manufacturing Lithium Batteries | $28.0M | 48% |
| Residential Energy Supply And Uninterruptable Supplies | $17.8M | 30% |
| Light Electric Vehicles | $12.9M | 22% |
| Precursor | $108.0K | 0% |
